skip to main content
Idioma:
Resultados 1 2 next page
Refinado por: assunto: Aged remover assunto: Oncology remover Biological And Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium
p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium
Material Type:
Artigo 		Adicionar ao Meu Espaço

p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium

Chaves, Paula ; Pereira, António Dias ; Pinto, António ; Oliveira, António Gouveia ; Queimado, Lurdes ; Glória, Luisa ; Cardoso, Paula ; Mira, Francisco Costa ; Soares, Jorge

Journal of surgical oncology, 1997-05, Vol.65 (1), p.3-9 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
2
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions
Material Type:
Artigo 		Adicionar ao Meu Espaço

The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions

Ferreira Filho, A. F. ; Di Leo, A. ; Paesmans, M. ; Beauduin, M. ; Vindevoghel, A. ; Michel, J. ; Focan, C. ; Awada, A. ; Cardoso, F. ; Dolci, S. ; Bartholomeus, S. ; Piccart, M. J.

Annals of oncology, 2002-03, Vol.13 (3), p.416-421 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
3
TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: Association with risk factors and tumor characteristics
TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: Association with risk factors and tumor characteristics
Material Type:
Artigo 		Adicionar ao Meu Espaço

TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: Association with risk factors and tumor characteristics

Simão, Tatiana A. ; Ribeiro, Fabiana S. ; Amorim, Lídia M. F. ; Albano, Rodolpho M. ; Andrada‐Serpa, Maria J. ; Cardoso, Lúis E. B. ; Mendonça, Gulnar A. S ; de Moura‐Gallo, Cláudia V.

International journal of cancer, 2002-09, Vol.101 (1), p.69-73 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
4
Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer
Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer

Cardoso, Fatima ; Di Leo, Angelo ; Piccart, Martine J.

Cancer treatment reviews, 2002-12, Vol.28 (6), p.275-290 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients

Bernard-Marty, C. ; Mano, M. ; Paesmans, M. ; Accettura, C. ; Munoz-Bermeo, R. ; Richard, T. ; Kleiber, K. ; Cardoso, F. ; Lobelle, J. P. ; Larsimont, D. ; Piccart, M. J. ; Di Leo, A.

Annals of oncology, 2003-05, Vol.14 (5), p.693-698 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
6
Correlation Between the Response to Cetuximab Alone or in Combination With Irinotecan and the Activated/Phosphorylated Epidermal Growth Factor Receptor in Metastatic Colorectal Cancer
Correlation Between the Response to Cetuximab Alone or in Combination With Irinotecan and the Activated/Phosphorylated Epidermal Growth Factor Receptor in Metastatic Colorectal Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correlation Between the Response to Cetuximab Alone or in Combination With Irinotecan and the Activated/Phosphorylated Epidermal Growth Factor Receptor in Metastatic Colorectal Cancer

Personeni, Nicola ; Hendlisz, Alain ; Gallez, Julien ; Galdon, Maria Gomez ; Larsimont, Denis ; Van Laethem, Jean-Luc ; Nagy, Nathalie ; Barette, Martine ; Paesmans, Marianne ; Cardoso, Fatima ; Bleiberg, Harry

Seminars in oncology, 2005-12, Vol.32 (6), p.59-62 [Periódico revisado por pares]

Philadelphia, PA: Elsevier Inc

Texto completo disponível

Citações Citado por
7
C-MYC Locus Amplification as Metastasis Predictor in Intestinal-type Gastric Adenocarcinomas: CGH Study in Brazil
C-MYC Locus Amplification as Metastasis Predictor in Intestinal-type Gastric Adenocarcinomas: CGH Study in Brazil
Material Type:
Artigo 		Adicionar ao Meu Espaço

C-MYC Locus Amplification as Metastasis Predictor in Intestinal-type Gastric Adenocarcinomas: CGH Study in Brazil

RODRIGUEZ BURBANO, Rommel ; PIMENTEL ASSUMPCAO, Paulo ; FERREIRA LEAL, Mariana ; QUEIROZ CALCAGNO, Danielle ; GUIMARAES, Adriana Costa ; SALIM KHAYAT, André ; SATOMI TAKENO, Sylvia ; CHEN, Elizabeth Suchi ; DE ARRUDA CARDOSO SMITH, Marilia

Anticancer research, 2006-07, Vol.26 (4B), p.2909-2914 [Periódico revisado por pares]

Attiki: International Institute of Anticancer Research

Texto completo disponível

Citações Citado por
8
A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 gene
A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 gene
Material Type:
Artigo 		Adicionar ao Meu Espaço

A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 gene

LOURENCO, Gustavo J ; CARDOSO-FILHO, Cassio ; GONCALES, Neiva S. L ; SHINZATO, Julia Y ; ZEFERINO, Luis C ; NASCIMENTO, Helvia ; COSTA, Fernando F ; GURGEL, Maria S. C ; LIMA, Carmen S. P

Breast cancer research and treatment, 2006-12, Vol.100 (3), p.335-338 [Periódico revisado por pares]

Dordrecht: Springer

Texto completo disponível

Citações Citado por
9
Current perspectives of epothilones in breast cancer
Current perspectives of epothilones in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Current perspectives of epothilones in breast cancer

Cardoso, Fatima ; de Azambuja, Evandro ; Lago, Lissandra Dal

European journal of cancer (1990), 2008-02, Vol.44 (3), p.341-352 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies

von Mehren, M. ; Schilder, R.J. ; Cheng, J.D. ; Temmer, E. ; Cardoso, T.M. ; Renshaw, F.G. ; Bayever, E. ; Zannikos, P. ; Yuan, Z. ; Cohen, R.B.

Annals of oncology, 2008-10, Vol.19 (10), p.1802-1809 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2002  (2)
  2. 2002Até2004  (4)
  3. 2005Até2007  (3)
  4. 2008Até2010  (4)
  5. Após 2010  (5)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.